Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
103,174,808
-
Share change
-
-3,937,876
-
Total reported value
-
$164,034,076
-
Put/Call ratio
-
3.3%
-
Price per share
-
$1.59
-
Number of holders
-
115
-
Value change
-
-$33,605,361
-
Number of buys
-
49
-
Number of sells
-
66
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q4 2018
As of 31 Dec 2018,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,174,808 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BlackRock Inc., Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC, MAK CAPITAL ONE LLC, STATE STREET CORP, ARMISTICE CAPITAL, LLC, and Rock Springs Capital Management LP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.